Siemens Healthineers AG (SMMNY)
Market Cap | 59.61B |
Revenue (ttm) | 27.46B |
Net Income (ttm) | 2.55B |
Shares Out | n/a |
EPS (ttm) | 2.27 |
PE Ratio | 23.37 |
Forward PE | 18.50 |
Dividend | 0.30 (1.10%) |
Ex-Dividend Date | Feb 20, 2025 |
Volume | 666 |
Average Volume | 33,010 |
Open | 26.65 |
Previous Close | 26.91 |
Day's Range | 26.55 - 26.76 |
52-Week Range | 23.28 - 30.19 |
Beta | 0.70 |
RSI | 43.71 |
Earnings Date | Jul 30, 2025 |
About ANSYS
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial StatementsNews

Siemens reduces stake in Siemens Healthineers to 71.12%
Siemens AG reduced its stake in medical technology company Siemens Healthineers by nearly 2 percentage points to 71.12%, according to a regulatory filing.
Siemens Healthineers AG 2025 Q3 - Results - Earnings Call Presentation

Siemens Healthineers AG (SEMHF) Q3 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q3 2025 Earnings Conference Call July 30, 2025 2:30 AM ET Company Participants Bernhard Montag - President, CEO & Chairman of Management Board Jochen Schmitz - CF...
Siemens Healthineers reports Q3 results

'Trade barriers bad for the patients': Siemens Healthineers CEO
Siemens Healthineers CEO Bernd Montag warns EU-U.S. trade barriers are driving up healthcare costs, as company releases its Q2 earnings report.

Siemens Healthineers meets Q3 sales expectations, raises guidance
German medical technology company Siemens Healthineers on Wednesday reported third-quarter revenue slightly above analysts' consensus, citing strong growth in its China business after declines last ye...
Siemens Healthineers: More Upside Is Possible

Siemens Healthineers Sets New Sustainability Benchmark as First IVD Manufacturer to Earn My Green Lab ACT Ecolabel for Analyzers, Reagents
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #healthcaredistribution--Siemens Healthineers has earned My Green Lab ACT Ecolabel Certification for more than 150 reagents used by medical laboratories for patient ...

Siemens Healthineers does not expect China restrictions to affect business
Siemens Healthineers does not expect the current developments in China to have a material impact on its business, a spokesperson for the German medical technology group said on Monday.

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight
New York, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight The expansion of the preeclampsia diagnostics market is...

Healthineers: Reviewing Q2 And Updating My Targets (Rating Upgrade)
Siemens Healthineers reported strong Q2 '25 results, with 7% top-line growth and confirmed full-year outlook, despite challenges in China and tariffs. The company excels in imaging, holding a 37% mark...
Siemens Healthineers AG 2025 Q2 - Results - Earnings Call Presentation
Siemens Healthineers AG (SEMHF) Q2 2025 Earnings Call Transcript
Siemens Healthineers AG reports Q2 results

Siemens Healthineers Posts Profit, Revenue Rise; Adjusts Guidance on Tariff Uncertainty
The healthcare-equipment company posted a rise in net profit and revenue for its fiscal second quarter but widened its adjusted earnings per share range on increased tariff uncertainty.

Siemens Healthineers posts revenue beat, but lowers floor of profit outlook
German medical technology group Siemens Healthineers posted second quarter revenue slightly above market expectations on Wednesday, but brought down the lower end of its annual earnings forecast due t...

Cardiovascular Image Fusion Software Market Analysis Report, 2025-2035, Featuring Ziehm Imaging, TeraRecon, OsiriX, Materialise, Siemens Healthineers and More
Dublin, May 05, 2025 (GLOBE NEWSWIRE) -- The "Cardiovascular Image Fusion Software Market - A Global and Regional Analysis: Focus on Application, End User, and Country-Level Analysis - Analysis and Fo...

More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025
PALO ALTO, Calif.--(BUSINESS WIRE)--Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025.

Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
Shenzhen, China--(Newsfile Corp. - February 28, 2025) - Recently, the world's first DSA-OCT integrated multi-modal diagnostic and treatment platform (ARTIS icono floor), jointly developed by Siemens H...
Siemens Set to Raise €1.4 Billion in Healthineers Stake Sale
Siemens AG is likely to raise about €1.4 billion ($1.5 billion) from the sale of a roughly 2.3% stake in Siemens Healthineers AG, the medical technology unit it listed in 2018, after increasing the si...

Siemens sells 2% stake in Siemens Healthineers
German engineering company Siemens announced late on Wednesday it launched a sale of a 2% stake in healthcare subsidiary Siemens Healthineers.
Siemens Healthineers AG goes ex dividend tomorrow
Siemens Healthineers: Why I'm 'HOLD'Ing After Q1 2025 (Rating Downgrade)
Siemens Healthineers AG (SEMHF) Q1 2025 Earnings Call Transcript
Siemens Healthineers AG 2025 Q1 - Results - Earnings Call Presentation
The following slide deck was published by Siemens Healthineers AG in conjunction with their 2025 Q1 earnings call.